Weijia Fu

31.4k total citations
24 papers, 204 citations indexed

About

Weijia Fu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Weijia Fu has authored 24 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Hematology. Recurrent topics in Weijia Fu's work include CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). Weijia Fu is often cited by papers focused on CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Congenital Diaphragmatic Hernia Studies (2 papers). Weijia Fu collaborates with scholars based in China, United States and United Kingdom. Weijia Fu's co-authors include Xue Hou, Lihua Dong, Wei Hou, Anna Plantinga, Ni Zhao, Ying Gu, Jos M. Latour, Michael C. Wu, Wei Li Adeline Koay and Angela Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Weijia Fu

20 papers receiving 203 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijia Fu China 8 95 34 26 20 19 24 204
Ayesha Baig Germany 4 61 0.6× 24 0.7× 33 1.3× 11 0.6× 25 1.3× 8 336
Danielle J. Dauphars United States 5 84 0.9× 39 1.1× 23 0.9× 13 0.7× 29 1.5× 7 352
Huda Asif Pakistan 8 75 0.8× 63 1.9× 58 2.2× 24 1.2× 27 1.4× 17 294
Mira Mousa United Arab Emirates 11 132 1.4× 51 1.5× 14 0.5× 26 1.3× 26 1.4× 20 366
Binshen Ouyang China 4 106 1.1× 27 0.8× 13 0.5× 13 0.7× 22 1.2× 9 167
Jessica Karta Luxembourg 2 154 1.6× 80 2.4× 16 0.6× 16 0.8× 16 0.8× 3 194
Yunjin Li China 8 136 1.4× 46 1.4× 31 1.2× 33 1.6× 11 0.6× 15 256
Guohui Xue China 9 96 1.0× 41 1.2× 25 1.0× 26 1.3× 61 3.2× 27 294

Countries citing papers authored by Weijia Fu

Since Specialization
Citations

This map shows the geographic impact of Weijia Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijia Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijia Fu more than expected).

Fields of papers citing papers by Weijia Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijia Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijia Fu. The network helps show where Weijia Fu may publish in the future.

Co-authorship network of co-authors of Weijia Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Weijia Fu. A scholar is included among the top collaborators of Weijia Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijia Fu. Weijia Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Weijia, et al.. (2025). Piezo1-related physiological and pathological processes in glioblastoma. Frontiers in Cell and Developmental Biology. 13. 1536320–1536320.
2.
Mouhieddine, Tarek H., Tianxiang Sheng, Weijia Fu, et al.. (2025). Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma. Bone Marrow Transplantation. 60(8). 1114–1119.
3.
Fu, Weijia, Jiahao Chen, & Xiaoxia Hu. (2025). Immune reconstitution following allogeneic hematopoietic cell transplantation and CAR-T therapy: dynamics, determinants, and directions. Best Practice & Research Clinical Haematology. 38(2). 101634–101634. 1 indexed citations
4.
Fu, Weijia, Yingwen Wang, Fan Zhang, et al.. (2025). Construction and validation of a pain facial expressions dataset for critically ill children. Scientific Reports. 15(1). 17214–17214.
5.
Friedman, Joseph I., Weijia Fu, Prem Timsina, et al.. (2025). Machine Learning Multimodal Model for Delirium Risk Stratification. JAMA Network Open. 8(5). e258874–e258874. 2 indexed citations
6.
Arinsburg, Suzanne, Tomer M. Mark, Christopher A. Fausel, et al.. (2024). Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma. Bone Marrow Transplantation. 59(10). 1440–1448. 1 indexed citations
7.
Wang, Yingwen, Weijia Fu, Yuejie Zhang, et al.. (2024). Constructing and implementing a performance evaluation indicator set for artificial intelligence decision support systems in pediatric outpatient clinics: an observational study. Scientific Reports. 14(1). 14482–14482. 2 indexed citations
8.
Patel, Rima, et al.. (2024). Low Dose Tamoxifen for Breast Cancer Prevention: A Real-World Experience. Clinical Breast Cancer. 25(3). 283–290. 2 indexed citations
9.
Kocarnik, Jonathan, Kelly Compton, Frances Dean, et al.. (2024). The global burden of primary liver cancer and underlying etiologies from 1990 to 2021.. Journal of Clinical Oncology. 42(16_suppl). 10573–10573.
10.
Fu, Weijia, Xue Hou, Lihua Dong, & Wei Hou. (2023). Roles of STAT3 in the pathogenesis and treatment of glioblastoma. Frontiers in Cell and Developmental Biology. 11. 1098482–1098482. 34 indexed citations
11.
12.
Liu, Zijing, Tiankai Xu, Pengyu Chang, et al.. (2023). Efficacy and safety of immune checkpoint inhibitors with or without radiotherapy in metastatic non-small cell lung cancer: A systematic review and meta-analysis. Frontiers in Pharmacology. 14. 1064227–1064227. 6 indexed citations
13.
Yu, Xiaohan, Haoyu Liu, Ning Chang, et al.. (2023). Circular RNAs: New players involved in the regulation of cognition and cognitive diseases. Frontiers in Neuroscience. 17. 1097878–1097878. 7 indexed citations
14.
Mouhieddine, Tarek H., Weijia Fu, Erin Moshier, et al.. (2023). Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy. Blood. 142(Supplement 1). 92–92. 2 indexed citations
15.
Mouhieddine, Tarek H., Weijia Fu, Erin Moshier, et al.. (2023). Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease. Blood. 142(Supplement 1). 1006–1006. 9 indexed citations
16.
Zhao, Ni, Anju Lulla, Anna Plantinga, et al.. (2022). Batch effects removal for microbiome data via conditional quantile regression. Nature Communications. 13(1). 5418–5418. 65 indexed citations
17.
Zhao, Rui-Wei, et al.. (2022). Multi-contrast High Quality MR Image Super-Resolution with Dual Domain Knowledge Fusion. 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). 2127–2134. 3 indexed citations
18.
Wang, Yang, Zhiqiang Song, Yuke Geng, et al.. (2022). The risk factors and early predictive model of hematotoxicity after CD19 chimeric antigen receptor T cell therapy. Frontiers in Oncology. 12. 3 indexed citations
19.
20.
Gu, Ying, et al.. (2020). Implementation of an Evidence-Based Guideline of Enteral Nutrition for Infants With Congenital Heart Disease: A Controlled Before-and-After Study*. Pediatric Critical Care Medicine. 21(6). e369–e377. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayesha Baig Breakdown of academic impact, for papers by Danielle J. Dauphars Breakdown of academic impact, for papers by Huda Asif Breakdown of academic impact, for papers by Mira Mousa Breakdown of academic impact, for papers by Binshen Ouyang Breakdown of academic impact, for papers by Jessica Karta Breakdown of academic impact, for papers by Yunjin Li Breakdown of academic impact, for papers by Guohui Xue
Rankless by CCL
2026